- Home
- RLAY vs WSFS Comparison
RLAY vs WSFS Comparison
Compare RLAY & WSFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLAY | WSFS |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.0B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | RLAY | WSFS |
|---|---|---|
| Price | $18.33 | $77.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | $27.58 | ★ $88.42 |
| AVG Volume (30 Days) | ★ 2.5M | 261.4K |
| Earning Date | 11-05-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | ★ 31.78 | 15.42 |
| EPS | N/A | ★ 3.26 |
| Revenue | $15,355,000.00 | ★ $963,949,000.00 |
| Revenue This Year | N/A | $7.28 |
| Revenue Next Year | $60.51 | $4.39 |
| P/E Ratio | ★ N/A | $23.55 |
| Revenue Growth | ★ 53.44 | 50.18 |
| 52 Week Low | $5.95 | $50.91 |
| 52 Week High | $21.27 | $82.94 |
Technical Indicators
Market Signals| Indicator | RLAY | WSFS |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 53.44 |
| Support Level | $17.67 | $76.71 |
| Resistance Level | $20.09 | $78.71 |
| Average True Range (ATR) | 0.97 | 1.29 |
| MACD | 0.10 | 0.28 |
| Stochastic Oscillator | 65.28 | 71.49 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About WSFS WSFS Financial Corporation
WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: the WSFS Bank segment provides loans and leases, and other financial products to commercial and consumer customers; the Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and the Wealth and Trust segment provides a broad array of planning and advisory services, investment management, trust services, and credit and deposit products to individual, corporate, and institutional clients. The majority of revenue is generated from the WSFS Bank segment.